GlassScriptPhysician profile
Craig N Dyess
NPI 1174138945
$5,156.92
in general payments reported to CMS, 2019-2025
12 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.33 · 2023: $3,330 · 2024: $1,459 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,733 · Food and Beverage: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,733.07 |
| Food and Beverage | $2,403.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,234.09 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $1,035.51 | 2024-2025 | Watchman Access System |
| Abbott Laboratories | $232.73 | 2023-2025 | Coroflow, Nc Trek Neo, Perclose Prostyle |
| Medtronic, INC. | $169.79 | 2024 | Azure Xt Dr Mri Surescan, Hawkone |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.36 | 2022-2025 | Lifevest |
| Inari Medical, INC. | $109.66 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $79.84 | 2023-2025 | Eliquis, Camzyos |
| Pfizer INC. | $43.67 | 2023 | |
| Heartflow, INC. | $36.49 | 2023 | Ffrct |
| Smith+Nephew, INC. | $24.38 | 2024 | Grafix Pl |
| Kestra Medical Technology Services, INC. | $15.03 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $13.37 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Dyess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.